411 related articles for article (PubMed ID: 28523551)
1. Epigenetic Mechanisms of Gene Regulation in Amyotrophic Lateral Sclerosis.
Jimenez-Pacheco A; Franco JM; Lopez S; Gomez-Zumaquero JM; Magdalena Leal-Lasarte M; Caballero-Hernandez DE; Cejudo-Guillén M; Pozo D
Adv Exp Med Biol; 2017; 978():255-275. PubMed ID: 28523551
[TBL] [Abstract][Full Text] [Related]
2. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.
Bruneteau G; Simonet T; Bauché S; Mandjee N; Malfatti E; Girard E; Tanguy ML; Behin A; Khiami F; Sariali E; Hell-Remy C; Salachas F; Pradat PF; Fournier E; Lacomblez L; Koenig J; Romero NB; Fontaine B; Meininger V; Schaeffer L; Hantaï D
Brain; 2013 Aug; 136(Pt 8):2359-68. PubMed ID: 23824486
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of epigenetic components in amyotrophic lateral sclerosis (ALS).
Lee J; Ryu H; Keum G; Yoon YJ; Kowall NW; Ryu H
Curr Med Chem; 2014; 21(31):3576-82. PubMed ID: 25005187
[TBL] [Abstract][Full Text] [Related]
4. ALS and FTD: an epigenetic perspective.
Belzil VV; Katzman RB; Petrucelli L
Acta Neuropathol; 2016 Oct; 132(4):487-502. PubMed ID: 27282474
[TBL] [Abstract][Full Text] [Related]
5. Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era.
Paez-Colasante X; Figueroa-Romero C; Sakowski SA; Goutman SA; Feldman EL
Nat Rev Neurol; 2015 May; 11(5):266-79. PubMed ID: 25896087
[TBL] [Abstract][Full Text] [Related]
6. Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease.
Bennett SA; Tanaz R; Cobos SN; Torrente MP
Transl Res; 2019 Feb; 204():19-30. PubMed ID: 30391475
[TBL] [Abstract][Full Text] [Related]
7. Epigenetics of Huntington's Disease.
Bassi S; Tripathi T; Monziani A; Di Leva F; Biagioli M
Adv Exp Med Biol; 2017; 978():277-299. PubMed ID: 28523552
[TBL] [Abstract][Full Text] [Related]
8. Impact of histone deacetylase inhibition and arimoclomol on heat shock protein expression and disease biomarkers in primary culture models of familial ALS.
Fernández Comaduran M; Minotti S; Jacob-Tomas S; Rizwan J; Larochelle N; Robitaille R; Sephton CF; Vera M; Nalbantoglu JN; Durham HD
Cell Stress Chaperones; 2024 Jun; 29(3):359-380. PubMed ID: 38570009
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Changes Associated with the Expression of Amyotrophic Lateral Sclerosis (ALS) Causing Genes.
Masala A; Sanna S; Esposito S; Rassu M; Galioto M; Zinellu A; Carru C; Carrì MT; Iaccarino C; Crosio C
Neuroscience; 2018 Oct; 390():1-11. PubMed ID: 30134203
[TBL] [Abstract][Full Text] [Related]
10. Aberrant regulation of DNA methylation in amyotrophic lateral sclerosis: a new target of disease mechanisms.
Martin LJ; Wong M
Neurotherapeutics; 2013 Oct; 10(4):722-33. PubMed ID: 23900692
[TBL] [Abstract][Full Text] [Related]
11. Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons.
Lasiene J; Komine O; Fujimori-Tonou N; Powers B; Endo F; Watanabe S; Shijie J; Ravits J; Horner P; Misawa H; Yamanaka K
Acta Neuropathol Commun; 2016 Feb; 4():15. PubMed ID: 26891847
[TBL] [Abstract][Full Text] [Related]
12. IN VITRO AND IN VIVO MODELS OF AMYOTROPHIC LATERAL SCLEROSIS: AN UPDATED OVERVIEW.
Gois AM; Mendonça DMF; Freire MAM; Santos JR
Brain Res Bull; 2020 Jun; 159():32-43. PubMed ID: 32247802
[TBL] [Abstract][Full Text] [Related]
13. Dysregulations of Expression of Genes of the Ubiquitin/SUMO Pathways in an In Vitro Model of Amyotrophic Lateral Sclerosis Combining Oxidative Stress and SOD1 Gene Mutation.
Dangoumau A; Marouillat S; Coelho R; Wurmser F; Brulard C; Haouari S; Laumonnier F; Corcia P; Andres CR; Blasco H; Vourc'h P
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670299
[TBL] [Abstract][Full Text] [Related]
14. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS.
Hayashi Y; Homma K; Ichijo H
Adv Biol Regul; 2016 Jan; 60():95-104. PubMed ID: 26563614
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylation and motor neuron degeneration.
Schmalbach S; Petri S
CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):279-84. PubMed ID: 20406183
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA Metabolism and Dysregulation in Amyotrophic Lateral Sclerosis.
Rinchetti P; Rizzuti M; Faravelli I; Corti S
Mol Neurobiol; 2018 Mar; 55(3):2617-2630. PubMed ID: 28421535
[TBL] [Abstract][Full Text] [Related]
17. Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model.
Rossaert E; Pollari E; Jaspers T; Van Helleputte L; Jarpe M; Van Damme P; De Bock K; Moisse M; Van Den Bosch L
Acta Neuropathol Commun; 2019 Jul; 7(1):107. PubMed ID: 31277703
[TBL] [Abstract][Full Text] [Related]
18. Why do motor neurons degenerate? Actualization in the pathogenesis of amyotrophic lateral sclerosis.
Riancho J; Gonzalo I; Ruiz-Soto M; Berciano J
Neurologia (Engl Ed); 2019; 34(1):27-37. PubMed ID: 26853842
[TBL] [Abstract][Full Text] [Related]
19. Trichostatin A Relieves Growth Suppression and Restores Histone Acetylation at Specific Sites in a FUS ALS/FTD Yeast Model.
Bennett SA; Cobos SN; Mirzakandova M; Fallah M; Son E; Angelakakis G; Rana N; Hugais M; Torrente MP
Biochemistry; 2021 Dec; 60(48):3671-3675. PubMed ID: 34788013
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
Harrison IF; Dexter DT
Pharmacol Ther; 2013 Oct; 140(1):34-52. PubMed ID: 23711791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
